Table 2. Clinical and biomarker correlations in patients with resistant hypertension evaluated in the study (N= 115).
Biomarker | Reference Range | Units | ARR versus | PRA versus | Serum Aldosterone versus | |||
All (N= 115) | - | - | R value | P value | R value | P value | R value | P value |
Baseline | - | - | - | - | - | - | - | - |
Age | - | years | 0.14 | 0.13 | -0.35 | 0.0001 | -0.14 | 0.15 |
PRA | 0.10-6.56 | ng/ml/hr | -0.28 | 0.002 | - | - | 0.01 | 0.90 |
S Aldosterone | 2.52-39.2 | ng/dL | 0.55 | 1E-10 | 0.01 | 0.90 | - | - |
HTN duration | - | years | 0.10 | 0.32 | -0.21 | 0.05 | -0.01 | 0.89 |
SBP highest | 90-120 | mmHg | -0.08 | 0.51 | 0.10 | 0.45 | -0.19 | 0.13 |
DBP highest | 60-80 | mmHg | 0.04 | 0.75 | 0.01 | 0.91 | 0.11 | 0.38 |
S Creatinine | 0.55-1.18 | mg/dl | 0.23 | 0.03 | 0.05 | 0.66 | 0.13 | 0.24 |
eGFR | - | ml/minute/1.73m2 | -0.24 | 0.02 | 0.05 | 0.63 | -0.04 | 0.69 |
Urine A:C ratio | <30 | µg/mg | 0.04 | 0.74 | -0.13 | 0.27 | 0.02 | 0.86 |
S Sodium | 135-150 | mEq/L | -0.05 | 0.66 | 0.10 | 0.36 | 0.05 | 0.64 |
S Potassium | 3.5-5.4 | mEq/L | -0.06 | 0.59 | -0.13 | 0.26 | -0.16 | 0.15 |
Current/Follow-Up | - | - | - | - | - | - | - | - |
SBP current | 90-120 | mmHg | -0.12 | 0.36 | -0.04 | 0.77 | 0.10 | 0.46 |
DBP current | 60-80 | mmHg | -0.09 | 0.52 | 0.3 | 0.02 | 0.17 | 0.23 |
Comorbidities | - | - | - | - | - | - | - | - |
ECHO EF% | 50-70 | % | -0.14 | 0.22 | 0.15 | 0.20 | 0.01 | 0.93 |